AU2001229768A1 - Amplified genes at 17q23 - Google Patents

Amplified genes at 17q23

Info

Publication number
AU2001229768A1
AU2001229768A1 AU2001229768A AU2976801A AU2001229768A1 AU 2001229768 A1 AU2001229768 A1 AU 2001229768A1 AU 2001229768 A AU2001229768 A AU 2001229768A AU 2976801 A AU2976801 A AU 2976801A AU 2001229768 A1 AU2001229768 A1 AU 2001229768A1
Authority
AU
Australia
Prior art keywords
amplified genes
genes
amplified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001229768A
Inventor
Maarit T. Barlund
Anne H. Kallioniemi
Olli P. Kallioniemi
Juha T. Kononen
Outi M. Monni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National Institutes of Health NIH
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Publication of AU2001229768A1 publication Critical patent/AU2001229768A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
AU2001229768A 2000-01-28 2001-01-24 Amplified genes at 17q23 Abandoned AU2001229768A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17906100P 2000-01-28 2000-01-28
US60/179,061 2000-01-28
PCT/US2001/002474 WO2001055450A2 (en) 2000-01-28 2001-01-24 AMPLIFIED GENES AT 17q23

Publications (1)

Publication Number Publication Date
AU2001229768A1 true AU2001229768A1 (en) 2001-08-07

Family

ID=22655070

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001229768A Abandoned AU2001229768A1 (en) 2000-01-28 2001-01-24 Amplified genes at 17q23

Country Status (2)

Country Link
AU (1) AU2001229768A1 (en)
WO (1) WO2001055450A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040029185A1 (en) * 2000-06-19 2004-02-12 Maaten Van Lohuizen Interaction of tbx2 and the arf promoter in cell cycle regulator assays
AU2003222058A1 (en) 2002-03-22 2003-10-13 The Government Of The United States Of America, Asrepresented By The Secretary, Department Of Health Materials and methods for inhibiting wip-1
WO2008065624A1 (en) * 2006-11-29 2008-06-05 Rheoscience A/S Interaction partner of neuronatin protein and uses thereof
EP2158327B1 (en) * 2007-06-03 2013-05-15 Oncotx, Inc. Cancer related isoforms of components of transcription factor complexes as biomarkers and drug targets
EP2385135B1 (en) * 2010-04-09 2015-09-09 Helmut Hanenberg RAD51C as a human cancer susceptibility gene
WO2013184905A1 (en) 2012-06-06 2013-12-12 Myriad Genetics, Inc. Hereditary cancer genes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6037125A (en) * 1996-11-05 2000-03-14 Lexicon Genetics Incorporated Disruption of the mammalian RAD51 protein and disruption of proteins that associate with mammalian RAD51 for hindering cell proliferation and/or viability of proliferating cells
WO1999065928A2 (en) * 1998-06-19 1999-12-23 Genzyme Corporation Polynucleotide population isolated from non-metastatic and metastatic breast tumor tissues
US6576759B2 (en) * 1999-02-10 2003-06-10 Pangene Corporation Antisense inhibition of RAD51

Also Published As

Publication number Publication date
WO2001055450A3 (en) 2003-01-23
WO2001055450A2 (en) 2001-08-02

Similar Documents

Publication Publication Date Title
WO2003018621A8 (en) Genes
AU2001228678A1 (en) Amplifier arrangement
AU2002245184A1 (en) Nucleic acid amplification
AU4657001A (en) Displacing arrangement
AU2001272482A1 (en) Osteolevin gene polymorphisms
AU2001252971A1 (en) Tiller
AU2001272764A1 (en) Photomultiplier
AU2001272762A1 (en) Photomultiplier
AU2001263157A1 (en) Tine system
AU2001232092A1 (en) Amplifier
AU4750500A (en) Amplifier
AU2001242625A1 (en) Gene sequence
AU2001240103A1 (en) Reproduction-specific genes
AU2001272763A1 (en) Photomultiplier
AU2001264247A1 (en) GASC1 gene
AU2001244358A1 (en) Schizophrenia related genes
AU2001229768A1 (en) Amplified genes at 17q23
EP1144631A3 (en) Insulin-synthesis genes
AUPR752101A0 (en) Amplifier improvements
AU7626201A (en) Stage construction
AU2001292079A1 (en) Raman amplification
AU2001247444A1 (en) Erbeta-mediated gene expression
AUPQ749100A0 (en) New epilespy gene
AU2001285743A1 (en) Adipose-related gene
AU2001284265A1 (en) Genetic study